73 filings
424B5
LYEL
Lyell Immunopharma Inc
6 May 24
Prospectus supplement for primary offering
8:12am
10-Q
2024 Q1
LYEL
Lyell Immunopharma Inc
Quarterly report
6 May 24
8:06am
8-K
LYEL
Lyell Immunopharma Inc
6 May 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
8:03am
EFFECT
LYEL
Lyell Immunopharma Inc
6 May 24
Notice of effectiveness
12:15am
ARS
2023 FY
LYEL
Lyell Immunopharma Inc
22 Apr 24
Annual report to shareholders
4:17pm
DEFA14A
0y88mpm8p9k9uglc89
22 Apr 24
Additional proxy soliciting materials
4:16pm
S-3
xck87mhjif
28 Feb 24
Shelf registration
7:49pm
S-8
tsa32ie9ijkx
28 Feb 24
Registration of securities for employees
7:40pm
8-K
781vdfwc bf60e1u
28 Feb 24
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
4:07pm
8-K
k5mcokzr3dk8hkx
20 Nov 23
Departure of Directors or Certain Officers
4:26pm
8-K
c614wc p44
7 Nov 23
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
4:08pm
8-K
ewg zzfzjx59qy425z3
11 Sep 23
Regulation FD Disclosure
9:16am
8-K
f939u7
8 Aug 23
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
4:10pm
8-K
3y799p
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:54pm
8-K
dmug67 wsfjg
6 Jun 23
Departure of Directors or Certain Officers
4:02pm